| Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin JS Lee, P Han, R Chaudhury, S Khan, S Bickerton, MD McHugh, HB Park, ... Nature Biomedical Engineering 5 (9), 983-997, 2021 | 44 | 2021 |
| Continuous label-free electronic discrimination of T cells by activation state P Han, S Yosinski, ZA Kobos, R Chaudhury, JS Lee, TM Fahmy, MA Reed ACS nano 14 (7), 8646-8657, 2020 | 29 | 2020 |
| Ex vivo dendritic cell generation—A critical comparison of current approaches P Han, D Hanlon, O Sobolev, R Chaudhury, RL Edelson International Review of Cell and Molecular Biology 349, 251-307, 2019 | 25 | 2019 |
| Exosomal MicroRNAs associate with neuropsychological performance in individuals with HIV infection on antiretroviral therapy T O'Meara, Y Kong, J Chiarella, RW Price, R Chaudhury, X Liu, S Spudich, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 82 (5), 514-522, 2019 | 15 | 2019 |
| Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin (vol 5, pg 983, 2021) JS Lee, P Han, R Chaudhury, S Khan, S Bickerton, MD McHugh, HB Park, ... Nature Biomedical Engineering 5 (11), 1403-1403, 2021 | 1 | 2021 |
| Direct Comparison of B Cell Surface Receptors as Therapeutic Targets for Nanoparticle Delivery of BTK Inhibitors SN Khan, P Han, R Chaudhury, S Bickerton, JS Lee, B Calderon, ... Molecular Pharmaceutics 18 (3), 850-861, 2021 | 1 | 2021 |
| Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin JS Lee, P Han, C Rabib, K Shihan, S Bickerton, MD McHugh, HB Park, ... Nature Biomedical Engineering 5 (11), 1403-1403, 2021 | | 2021 |
